Latest News

Athens, Greece (UroToday.com) Dr. Georg Salomon presented the novel multiparametric ultrasound for prostate cancer detection and localization, and its correlation to ultrasound B mode, shear wave elastography, and contrast-enhanced ultrasound with radical prostatectomy specimens. Multiparametric MRI (mpMRI) is superior to systematic biopsies with fewer cores, and lower detection rate of insignificant cancer1. However, it has some […]

Athens, Greece (Urotoday.com) Neoadjuvant chemotherapy (NAC) in bladder cancer has been proven to improve overall survival in patients with muscle-invasive bladder cancer (MIBC) over 15 years ago1. Accurate preoperative prediction of pathological T0 could perhaps spare cystectomy in a significant portion of patients2. NAC compared to TURBT alone has shown a significant advantage with a higher […]

Athens, Greece (Urotoday.com) In this debate a 65-year-old man, who was a heavy smoker, with hematuria was presented. On ultrasound, he was found to have a large solid mass 4.5 *4 cm in the left lateral bladder wall. He underwent TURBT surgery and the pathology revealed a transitional cell carcinoma deeply invading the lamina propria, with […]

Athens, Greece (Urotoday.com) In this debate a 65-year-old man, who was a heavy smoker, with hematuria was presented. On ultrasound, he was found to have a large solid mass 4.5 *4 cm in the left lateral bladder wall. He underwent TURBT surgery and the pathology revealed a transitional cell carcinoma deeply invading the lamina propria, with […]

Athens, Greece (UroToday.com) Dr. Kelly Stratton gave an overview of the role of surgery in advanced prostate cancer. Advanced prostate cancer is a growing concern with the non-organed confined disease at prostatectomy becoming more prevalent.1 According to the EAU guidelines locally advanced disease is a disease manifesting with any PSA, and Gleason score, clinical stage T3-T4 or […]

Athens, Greece (Urotoday.com) Dr. Renu Eapen gave a talk on the imaging options of patients with biochemical recurrence (BCR) after radical prostatectomy. BCR is generally defined as a detectable PSA level of 0.2 ng/ml or higher after radical prostatectomy (according to the AUA and EAU guidelines). There are many variables related to and affecting BCR. […]

Athens, Greece (UroToday.com) At this year’s Annual Society of International Urology Conference (SIU 2019), Dr. Peter Carroll gave an overview of active surveillance (AS) for early-stage prostate cancer.The goals of AS include: To avoid or delay the costs of treatment without compromising cancer cure To be compliant with screening guidelines Needs to be based on […]

Athens, Greece (UroToday.com) Dr. James Eastham ended the Master class session giving a talk on the oncologic outcome and patterns of recurrence after salvage radical prostatectomy. Biochemical failure after radiotherapy is most commonly defined using the ASTRO Phoenix definition of PSA nadir + 2, which entails 3 consecutive rises in PSA levels at least 6 […]

Athens, Greece (UroToday.com) Dr. R. Jeffrey Karnes gave a presentation overview of the treatment options of patients with biochemical recurrence (BCR) after radical prostatectomy (RP). He began his talk with some important observations: BCR occurs in one-third of patients by 10 years following RP. We now have level one evidence from the RADICALS trial1 showing […]